What is the first‑line treatment for a fungal infection of the buttocks (tinea corporis or cutaneous candidiasis)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 19, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Fungal Infection in the Buttocks Area

For fungal infections of the buttocks, start with topical antifungal therapy as first-line treatment, using either terbinafine 1% cream once daily for 1-2 weeks or an azole cream (clotrimazole or miconazole) twice daily for 2-4 weeks. 1, 2

Determining the Type of Infection

The buttocks can be affected by two main types of fungal infections:

  • Tinea corporis (dermatophyte infection): Typically presents as ring-shaped lesions with raised borders and central clearing 3, 4
  • Cutaneous candidiasis: More common in skin folds, presents as red, macerated patches with satellite lesions 5, 6

First-Line Topical Treatment

For Tinea Corporis (Dermatophyte Infection)

Terbinafine 1% cream is the preferred first-line agent, applied once daily for 1-2 weeks, with approximately 94% mycological cure rate 1, 2

Alternative topical options include:

  • Clotrimazole cream applied twice daily for 2-4 weeks 1
  • Miconazole cream applied twice daily for 2-4 weeks 1
  • Ketoconazole 2% cream for tinea corporis caused by Trichophyton rubrum, T. mentagrophytes, and Epidermophyton floccosum 6

For Cutaneous Candidiasis

Ketoconazole 2% cream is FDA-approved for cutaneous candidiasis caused by Candida species 6

Alternative azole creams (clotrimazole, miconazole) are equally effective for candidal infections 5, 3

When to Use Oral Antifungal Therapy

Oral therapy is indicated when: 1, 4

  • The infection is extensive or covers a large area
  • Topical treatment has failed after 2-4 weeks
  • The patient is immunocompromised
  • The infection is recurrent

Oral Treatment Options

For dermatophyte infections (tinea corporis):

  • Terbinafine 250 mg daily for 1-2 weeks is particularly effective against Trichophyton species 1, 7
  • Itraconazole 100 mg daily for 15 days achieves 87% mycological cure rate and is effective against both Trichophyton and Microsporum species 1, 7

For candidal infections:

  • Fluconazole is first-line for mucosal and cutaneous candidiasis 5
  • Itraconazole should be considered first-line for Candida infections, given its shorter treatment duration compared to other options 5

Critical Treatment Principles

Continue treatment for at least one week after clinical clearing to ensure mycological cure, not just symptomatic improvement 2, 4

The definitive endpoint must be mycological cure (negative microscopy and culture), not just clinical response 1, 7

Prevention of Recurrence

To prevent reinfection, implement these measures: 1, 2

  • Keep the area completely dry after bathing before dressing
  • Avoid skin-to-skin contact with infected individuals
  • Do not share towels or personal items
  • Wear breathable, loose-fitting clothing
  • If concurrent tinea pedis (athlete's foot) is present, treat it simultaneously and put on socks before underwear to prevent contamination of the groin/buttocks area 2

Important Safety Considerations

Baseline liver function tests are recommended before initiating oral terbinafine or itraconazole, especially with pre-existing hepatic abnormalities 1, 7

Itraconazole has significant drug interactions with warfarin, certain antihistamines, antipsychotics, midazolam, digoxin, and simvastatin 7, 5

Common Pitfalls to Avoid

  • Do not stop treatment when symptoms improve clinically – continue until mycological cure is achieved to prevent recurrence 1, 2
  • Do not use combination antifungal/steroid creams long-term due to potential for skin atrophy and steroid-associated complications 4
  • Screen and treat household contacts if the infection is caused by anthropophilic species, as over 50% of family members may be affected 1, 2

References

Guideline

Treatment of Tinea Corporis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Recurrent Tinea Cruris

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Topical treatment of common superficial tinea infections.

American family physician, 2002

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Antifungal Treatment for Tinea and Dermatophytes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the diagnosis and treatment for itchy, foul-smelling, dark discolored and raised skin areas below the navel extending to the thigh, lasting 2 months, in a patient with morbid obesity and red eyes?
What is the treatment for recurrent cutaneous fungal infections?
What are the recommended first‑line treatment guidelines for an elderly patient with a localized groin fungal infection (tinea cruris or intertriginous candidiasis) who is afebrile?
What is the first-line treatment for an adult patient with tinea corporis, a fungal infection of the skin?
What are the current treatment options for Tinea (ringworm) infections?
Can an eight-year-old healthy child receive an annual influenza vaccine?
Is high-dose beta‑carotene supplementation safe for a patient with liver cirrhosis, particularly if they smoke or have a history of alcohol use?
What are the differences between monopolar and bipolar electrosurgical cautery?
What is the immediate management of a food bolus impacted in the lower esophagus?
What is the appropriate management for a patient with fasting hypoglycemia (glucose 57 mg/dL), stage 3 chronic kidney disease (creatinine 1.39 mg/dL, eGFR ≈48 mL/min), anemia (hemoglobin 9.4 g/dL, macrocytosis, elevated RDW), leukocytosis with neutrophil predominance, normal vitamin B12 and vitamin D, and hypoalbuminemia (serum albumin 3 g/dL)?
Can glucagon be used as initial therapy for an adult with an acute esophageal food bolus obstruction (e.g., smooth‑muscle spasm or Schatzki ring), and what is the recommended dose, repeat dosing, contraindications, and next steps if it fails?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.